Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Retained Earnings (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Retained Earnings for 10 consecutive years, with -$275.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Retained Earnings fell 16.83% to -$275.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$275.2 million, a 16.83% decrease, with the full-year FY2025 number at -$275.2 million, down 16.83% from a year prior.
  • Retained Earnings was -$275.2 million for Q4 2025 at Orthopediatrics, down from -$265.1 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$3.7 million in Q2 2022 to a low of -$275.2 million in Q4 2025.
  • A 5-year average of -$127.6 million and a median of -$176.3 million in 2021 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: plummeted 265917.91% in 2021, then skyrocketed 97.91% in 2022.
  • Orthopediatrics' Retained Earnings stood at -$178.0 million in 2021, then increased by 0.71% to -$176.8 million in 2022, then skyrocketed by 96.87% to -$5.5 million in 2023, then crashed by 4162.83% to -$235.6 million in 2024, then dropped by 16.83% to -$275.2 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Retained Earnings are -$275.2 million (Q4 2025), -$265.1 million (Q3 2025), and -$253.3 million (Q2 2025).